NNOX Quote, Financials, Valuation and Earnings

Intelligent Bio Solutions, Inc. has a net margin of -396.98% compared to Nano-X Imaging Ltd.'s net margin of -269.38%. Nano-X Imaging Ltd.'s return on equity of -32.75% beat Intelligent Bio Solutions, Inc.'s return on equity of -255.54%.

Nano-X Imaging Ltd. has a consensus price target of $8.15, signalling upside risk potential of 172.58%. On the other hand Intelligent Bio Solutions, Inc. has an analysts' consensus of -- which suggests that it could grow by 1854.4%. Given that Intelligent Bio Solutions, Inc. has higher upside potential than Nano-X Imaging Ltd., analysts believe Intelligent Bio Solutions, Inc. is more attractive than Nano-X Imaging Ltd..

Nano-X Imaging Ltd. has a beta of 1.070, which suggesting that the stock is 6.959% more volatile than S&P 500. In comparison Intelligent Bio Solutions, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Nano-X Imaging Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intelligent Bio Solutions, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nano-X Imaging Ltd. pays -- of its earnings as a dividend. Intelligent Bio Solutions, Inc. pays out -- of its earnings as a dividend.

Nano-X Imaging Ltd. quarterly revenues are $3.4M, which are larger than Intelligent Bio Solutions, Inc. quarterly revenues of $1.1M. Nano-X Imaging Ltd.'s net income of -$13.7M is lower than Intelligent Bio Solutions, Inc.'s net income of -$3M. Notably, Nano-X Imaging Ltd.'s price-to-earnings ratio is -- while Intelligent Bio Solutions, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nano-X Imaging Ltd. is 15.33x versus 12.21x for Intelligent Bio Solutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Standard BioTools, Inc. has a net margin of -396.98% compared to Nano-X Imaging Ltd.'s net margin of -162.05%. Nano-X Imaging Ltd.'s return on equity of -32.75% beat Standard BioTools, Inc.'s return on equity of -24.44%.

Nano-X Imaging Ltd. has a consensus price target of $8.15, signalling upside risk potential of 172.58%. On the other hand Standard BioTools, Inc. has an analysts' consensus of $1.65 which suggests that it could fall by -4.91%. Given that Nano-X Imaging Ltd. has higher upside potential than Standard BioTools, Inc., analysts believe Nano-X Imaging Ltd. is more attractive than Standard BioTools, Inc..

Nano-X Imaging Ltd. has a beta of 1.070, which suggesting that the stock is 6.959% more volatile than S&P 500. In comparison Standard BioTools, Inc. has a beta of 1.236, suggesting its more volatile than the S&P 500 by 23.585%.

Nano-X Imaging Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nano-X Imaging Ltd. pays -- of its earnings as a dividend. Standard BioTools, Inc. pays out -- of its earnings as a dividend.

Nano-X Imaging Ltd. quarterly revenues are $3.4M, which are smaller than Standard BioTools, Inc. quarterly revenues of $19.6M. Nano-X Imaging Ltd.'s net income of -$13.7M is higher than Standard BioTools, Inc.'s net income of -$31.7M. Notably, Nano-X Imaging Ltd.'s price-to-earnings ratio is -- while Standard BioTools, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nano-X Imaging Ltd. is 15.33x versus 4.80x for Standard BioTools, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

LENSAR, Inc. has a net margin of -396.98% compared to Nano-X Imaging Ltd.'s net margin of -25.94%. Nano-X Imaging Ltd.'s return on equity of -32.75% beat LENSAR, Inc.'s return on equity of -1013.45%.

Nano-X Imaging Ltd. has a consensus price target of $8.15, signalling upside risk potential of 172.58%. On the other hand LENSAR, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 24.9%. Given that Nano-X Imaging Ltd. has higher upside potential than LENSAR, Inc., analysts believe Nano-X Imaging Ltd. is more attractive than LENSAR, Inc..

Nano-X Imaging Ltd. has a beta of 1.070, which suggesting that the stock is 6.959% more volatile than S&P 500. In comparison LENSAR, Inc. has a beta of 0.665, suggesting its less volatile than the S&P 500 by 33.53%.

Nano-X Imaging Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LENSAR, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nano-X Imaging Ltd. pays -- of its earnings as a dividend. LENSAR, Inc. pays out -- of its earnings as a dividend.

Nano-X Imaging Ltd. quarterly revenues are $3.4M, which are smaller than LENSAR, Inc. quarterly revenues of $14.3M. Nano-X Imaging Ltd.'s net income of -$13.7M is lower than LENSAR, Inc.'s net income of -$3.7M. Notably, Nano-X Imaging Ltd.'s price-to-earnings ratio is -- while LENSAR, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nano-X Imaging Ltd. is 15.33x versus 2.41x for LENSAR, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Xylo Technologies Ltd. has a net margin of -396.98% compared to Nano-X Imaging Ltd.'s net margin of --. Nano-X Imaging Ltd.'s return on equity of -32.75% beat Xylo Technologies Ltd.'s return on equity of -51.7%.

Nano-X Imaging Ltd. has a consensus price target of $8.15, signalling upside risk potential of 172.58%. On the other hand Xylo Technologies Ltd. has an analysts' consensus of $9.00 which suggests that it could grow by 77.52%. Given that Nano-X Imaging Ltd. has higher upside potential than Xylo Technologies Ltd., analysts believe Nano-X Imaging Ltd. is more attractive than Xylo Technologies Ltd..

Nano-X Imaging Ltd. has a beta of 1.070, which suggesting that the stock is 6.959% more volatile than S&P 500. In comparison Xylo Technologies Ltd. has a beta of 0.148, suggesting its less volatile than the S&P 500 by 85.241%.

Nano-X Imaging Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xylo Technologies Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $3.94 per share. Nano-X Imaging Ltd. pays -- of its earnings as a dividend. Xylo Technologies Ltd. pays out -- of its earnings as a dividend.

Nano-X Imaging Ltd. quarterly revenues are $3.4M, which are larger than Xylo Technologies Ltd. quarterly revenues of --. Nano-X Imaging Ltd.'s net income of -$13.7M is higher than Xylo Technologies Ltd.'s net income of --. Notably, Nano-X Imaging Ltd.'s price-to-earnings ratio is -- while Xylo Technologies Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nano-X Imaging Ltd. is 15.33x versus 0.13x for Xylo Technologies Ltd.. Usually stocks with elevated PS ratios are considered overvalued.